英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Ambroxol EP Impurity A |
2-氨基-3,5-二溴芐醇 |
50739-76-9 |
詳細(xì)
|
Cinnarizine EP Impurity B |
桂利嗪雜質(zhì)B |
750512-44-8 |
詳細(xì)
|
Cinnarizine EP Impurity C |
桂利嗪雜質(zhì)C |
95062-18-3 |
詳細(xì)
|
Cinnarizine EP Impurity D |
桂利嗪EP雜質(zhì)D |
1415587-79-9 |
詳細(xì)
|
6-Hydroxy Chlorzoxazone |
6-.羥基氯唑沙宗 |
1750-45-4 |
詳細(xì)
|
Carbazochrome impurity 1 |
卡絡(luò)磺鈉雜質(zhì)7 |
2666934-59-2 |
詳細(xì)
|
Pazopanib Impurity 1 |
2-氯-4-羥基嘧啶 |
55873-09-1 |
詳細(xì)
|
Ranolazine USP Related Compound A |
愈創(chuàng)木酚縮水甘油醚 |
2210-74-4 |
詳細(xì)
|
Avanafil Impurity 30 |
阿伐那非雜質(zhì)26 |
2250242-42-1 |
詳細(xì)
|
Avanafil Impurity 32 |
4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2R)-2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲酰胺 |
1638497-26-3 |
詳細(xì)
|
Avanafil Impurity 38 |
阿伐那非雜質(zhì) |
330785-05-2 |
詳細(xì)
|
Flucloxacillin sodium EP Impurity B |
FLUCLOXACILLIN |
1276016-89-7 |
詳細(xì)
|
Flucloxacillin sodium EP Impurity C |
6-氨基青霉烷酸 |
551-16-6 |
詳細(xì)
|
Flucloxacillin sodium EP Impurity E |
氟氯西林EP雜質(zhì)E |
1483237-81-5 |
詳細(xì)
|
Tranexamic Acid EP Impurity B |
4-(氨基甲基)環(huán)己酸 |
1197-17-7 |
詳細(xì)
|
Tranexamic Acid EP Impurity C |
氨甲環(huán)酸雜質(zhì)C |
330838-52-3 |
詳細(xì)
|
Tranexamic Acid EP Impurity F |
氨甲環(huán)酸雜質(zhì)F |
1599413-49-6 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity A |
霉酚酸酯雜質(zhì)A |
1322681-36-6 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity C |
霉酚酸酯EP雜質(zhì)C |
2286278-51-9 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity E |
霉酚酸酯雜質(zhì)E |
31858-66-9 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity F |
霉酚酸 |
24280-93-1 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity G |
霉酚酸酯雜質(zhì)G |
224052-51-1 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity H |
霉酚酸酯EP雜質(zhì)H(霉酚酸酯-USP相關(guān)化合物B) |
26675-76-3 |
詳細(xì)
|
Mycophenolate Mofetil Impurity 1 |
霉酚羥基內(nèi)酯 |
26644-06-4 |
詳細(xì)
|
Nicardipine Impurity 10 |
尼卡地平雜質(zhì)26 |
167963-66-8 |
詳細(xì)
|
Nicardipine Impurity 11 |
尼卡地平雜質(zhì)24 |
40641-47-2 |
詳細(xì)
|
Nicardipine Impurity 12 |
|
132100-30-2 |
詳細(xì)
|
Benidipine Impurity 4 |
2-BUTENOIC ACID, 3-AMINO-, 1-(PHENYLMETHYL)-3-PIPERIDINYL ESTER |
91599-78-9 |
詳細(xì)
|
Benidipine Impurity 6 |
3-芐氧基哌啶 |
1185304-22-6 |
詳細(xì)
|
Benidipine Impurity 7 |
1-芐基-3-羥基氯化吡啶 |
3323-73-7 |
詳細(xì)
|
Cycloserine Impurity 2 |
環(huán)絲氨酸雜質(zhì)5 |
15996-22-2 |
詳細(xì)
|
Cycloserine Impurity 3 |
3,6-雙(2-羥乙基)-2,5-二酮哌嗪 |
50975-79-6 |
詳細(xì)
|
Cycloserine Impurity 4 |
乙酰半胱氨酸雜質(zhì) |
16337-02-3 |
詳細(xì)
|
Cycloserine Impurity 5 |
環(huán)絲氨酸雜質(zhì)8 |
15996-16-4 |
詳細(xì)
|
Salbutamol EP Impurity A |
沙丁胺醇雜質(zhì)A |
870076-72-5 |
詳細(xì)
|
Salbutamol EP Impurity B |
沙丁胺醇EP雜質(zhì)B |
96948-64-0 |
詳細(xì)
|
Salbutamol EP Impurity J |
沙丁胺醇相關(guān)物質(zhì)B |
156547-62-5 |
詳細(xì)
|
Rocuronium Bromide Impurity 2 |
5alpha-雄甾-2-烯-17-酮 |
963-75-7 |
詳細(xì)
|
Duloxetine EP Impurity F |
度洛西汀EP雜質(zhì)F |
959392-22-4 |
詳細(xì)
|
Duloxetine EP Impurity G |
1-氟萘 |
321-38-0 |
詳細(xì)
|
Duloxetine EP Impurity E |
度洛西汀EP雜質(zhì)E |
1033803-59-6 |
詳細(xì)
|
Duloxetine EP Impurity C |
(RS)-4-[3-甲氨基-1-(2-噻吩基)丙基]-1-萘酚 |
949095-98-1 |
詳細(xì)
|
Duloxetine EP Impurity B |
(S)-3-(甲氨基)-1-(2-噻吩基)-1-丙醇 |
116539-55-0 |
詳細(xì)
|
Trazodone EP Impurity M |
Isotrazodone |
157072-18-9 |
詳細(xì)
|
Trazodone EP Impurity H 2HCl |
Trazodone Hydrochloride BP Impurity H DiHCl |
2408971-27-5 |
詳細(xì)
|
Trazodone EP Impurity G 2HCl |
鹽酸曲唑酮EP雜質(zhì)G |
2512213-25-9 |
詳細(xì)
|
Trazodone EP Impurity G HCl |
雜質(zhì)曲唑酮鹽酸G |
2470441-00-8 |
詳細(xì)
|
Trazodone EP Impurity D |
Trazodone impurity 3/Trazodone Bromo Analog/2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one |
1263358-13-9 |
詳細(xì)
|
Trazodone EP Impurity C |
4-Chloro Trazodone |
157072-19-0 |
詳細(xì)
|
Trazodone EP Impurity A HCl |
曲唑酮USP雜質(zhì)A |
55290-66-9 |
詳細(xì)
|
Eltrombopag Impurity 21 |
Diazene, 1,2-bis(3,4-dimethylphenyl)- |
29418-36-8 |
詳細(xì)
|
Cyanocobalamin EP Impurity E |
氰鈷銨素雜質(zhì) |
41325-63-7 |
詳細(xì)
|
Duloxetine EP Impurity A |
R-(-)-度洛西汀 |
116539-60-7 |
詳細(xì)
|
Tazobactam USP Related Compound A |
[S-(R*,R*)]-α-AMino-β-Methyl-β-sulfino-1H-1,2,3-triazole-1-butanoic Acid |
120701-87-3 |
詳細(xì)
|
Trazodone Impurity 2 HCl |
鹽酸曲唑酮雜質(zhì)18 |
1263278-79-0 |
詳細(xì)
|
Trazodone Impurity 1 |
1-(3-氯苯基)-4-(3-氯丙基)哌嗪 |
39577-43-0 |
詳細(xì)
|
Cyanocobalamin EP Impurity D |
氰鈷銨素雜質(zhì) |
121483-62-3 |
詳細(xì)
|
Cyanocobalamin EP Impurity C |
34-甲基氰鈷胺 |
38218-51-8 |
詳細(xì)
|
Biotin Impurity 1 |
吡哆素雜質(zhì)33 |
4375-00-2 |
詳細(xì)
|
Biotin EP Impurity G Bromide |
生物素EP雜質(zhì)G溴化物 |
33719-11-8 |
詳細(xì)
|
Biotin EP Impurity F |
生物素EP雜質(zhì)F |
101469-35-6 |
詳細(xì)
|
Biotin EP Impurity D |
生物素雜質(zhì)D |
415725-35-8 |
詳細(xì)
|
Biotin EP Impurity C |
生物素雜質(zhì) |
22342-46-7 |
詳細(xì)
|
Biotin EP Impurity B |
生物素雜質(zhì)B |
57671-79-1 |
詳細(xì)
|
Rocuronium Bromide Impurity 3 |
5-雄甾-3-烯-17-酮 |
14935-81-0 |
詳細(xì)
|
Landiolol Impurity 25 |
蘭地洛爾雜質(zhì)30 |
2414593-71-6 |
詳細(xì)
|
Landiolol Impurity 35 |
N-(2-氨基乙基)-4-嗎啉甲酰胺草酸鹽 |
154467-16-0 |
詳細(xì)
|
Nicardipine EP Impurity A DiHCl |
鹽酸尼卡地平EP雜質(zhì)A二鹽酸鹽 |
2724726-76-3 |
詳細(xì)
|
Ranolazine USP Related Compound B |
雷諾嗪雜質(zhì) |
755711-09-2 |
詳細(xì)
|
Ranolazine USP Related Compound C |
N-(2,6-二甲基苯基)-1-哌嗪乙酰胺 |
5294-61-1 |
詳細(xì)
|
Neostigmine EP Impurity B |
3-羥基-N,N-二甲基苯胺 |
99-07-0 |
詳細(xì)
|
Neostigmine EP Impurity C |
N,N-二甲基氨基甲酸-3-(二甲基氨基)苯酯 |
16088-19-0 |
詳細(xì)
|
Neostigmine Impurity 1 |
新斯的明二聚體 |
63468-95-1 |
詳細(xì)
|
Landiolol Impurity 1 |
蘭地洛爾雜質(zhì)7 |
144256-26-8 |
詳細(xì)
|
Landiolol Impurity 1 HCl |
鹽酸蘭地洛爾異構(gòu)體Ⅱ |
1253907-85-5 |
詳細(xì)
|
Landiolol Impurity 2 |
蘭地洛爾雜質(zhì)8 |
144256-25-7 |
詳細(xì)
|
Landiolol Impurity 2 HCl |
鹽酸蘭地洛爾異構(gòu)體Ⅰ |
1253907-83-3 |
詳細(xì)
|
Landiolol Impurity 3 |
蘭地洛爾雜質(zhì)2 |
133242-29-2 |
詳細(xì)
|
Landiolol Impurity 3 HCl |
鹽酸蘭地洛爾異構(gòu)體Ⅲ |
1253907-81-1 |
詳細(xì)
|
Landiolol Impurity 4 |
蘭地洛爾雜質(zhì)40 |
4432-25-1 |
詳細(xì)
|
Landiolol Impurity 5 |
蘭地洛爾雜質(zhì)32 |
93605-74-4 |
詳細(xì)
|
Landiolol Impurity 6 |
蘭地洛爾雜質(zhì)28 |
69630-20-2 |
詳細(xì)
|
Landiolol Impurity 7 |
蘭地洛爾雜質(zhì)2 |
2180628-04-8 |
詳細(xì)
|
Landiolol Impurity 11 |
144256-12-2 |
144256-12-2 |
詳細(xì)
|
Landiolol Impurity 18 |
蘭地洛爾雜質(zhì) |
190601-22-0 |
詳細(xì)
|
Posaconazole Impurity 20 |
泊沙康唑雜質(zhì) |
170985-61-2 |
詳細(xì)
|
Posaconazole Impurity 21 |
泊沙康唑雜質(zhì) |
171228-50-5 |
詳細(xì)
|
Posaconazole Impurity 22 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-99-9 |
詳細(xì)
|
Posaconazole Impurity 23 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-97-7 |
詳細(xì)
|
Posaconazole Impurity 24 |
4-[4-[4-[4-[[(3R,5S)-5-(2,4-二氟苯基)四氫-5-(1H-1,2,4-三唑-1-基甲基)-3-呋喃基]甲氧基]苯基]-1-哌嗪基]苯基]-2-[(1S,2S)-1-乙基-2-羥丙基]-2,4-二氫-3H-1,2,4-三唑-3-酮 |
2243785-96-6 |
詳細(xì)
|
Posaconazole Impurity 25 |
泊沙康唑雜質(zhì)20 |
1229428-91-4 |
詳細(xì)
|
Posaconazole Impurity 26 |
泊沙康唑雜質(zhì) |
1229428-90-3 |
詳細(xì)
|
Posaconazole Impurity 27 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-98-8 |
詳細(xì)
|
Posaconazole Impurity 28 |
泊沙康唑雜質(zhì)28 |
186805-99-2 |
詳細(xì)
|
Posaconazole Impurity 31 |
泊沙康唑雜質(zhì)23 |
687132-01-0 |
詳細(xì)
|
Posaconazole Impurity 34 |
泊沙康唑雜質(zhì)39 |
161532-65-6 |
詳細(xì)
|
Perindopril EP Impurity P |
1-[2-[[1-(ethoxycarbonyl)butyl]amino]propionyl]octahydro-1H-indole-2-carboxylic acid |
82978-68-5 |
詳細(xì)
|
Perindopril L-Arginine |
培哚普利精氨酸 |
612548-45-5 |
詳細(xì)
|
Perindopril Impurity 9 |
培哚普利雜質(zhì)19 |
145513-38-8 |
詳細(xì)
|
Perindopril Impurity 10 |
培哚普利EP雜質(zhì)A |
145513-32-2 |
詳細(xì)
|